Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $7.9250, but opened at $8.65. Oxford BioMedica shares last traded at $8.65, with a volume of 346 shares.
Oxford BioMedica Stock Up 8.3%
The firm has a fifty day simple moving average of $8.11 and a two-hundred day simple moving average of $8.94.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Recommended Stories
- Five stocks we like better than Oxford BioMedica
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
- Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
